{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:18:31Z","timestamp":1697534311072},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":9742,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1993]]},"DOI":"10.1254\/jjp.63.269","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:09:52Z","timestamp":1201151392000},"page":"269-278","source":"Crossref","is-referenced-by-count":5,"title":["Terguride as a New Anti-Hyperprolactinemic Agent: Characterization in Rats and Dogs in Comparison with Bromocriptine"],"prefix":"10.1016","volume":"63","author":[{"given":"Tatsuo","family":"Mizokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Akai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motonori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Juergen","family":"Rettig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Wachtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.63.269_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem-53-4-737","article-title":"Size reduction of macroprolactinomas by bromocriptine or lisuride treatment","volume":"53","author":"Chiodini","year":"1981","journal-title":"J. Clin. Endocrinol."},{"key":"10.1254\/jjp.63.269_bib2","series-title":"Lisuride and Other Dopamine Agonists","first-page":"301","article-title":"Suppression of lactation","author":"Schmidt-Gollwitzer","year":"1983"},{"key":"10.1254\/jjp.63.269_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00006250-198003000-00002","article-title":"Bromocriptine mesylate (Parlodel) in the management of amenorrhea\/galactorrhea associated with hyperprolactinemia","volume":"55","author":"Cuellar","year":"1980","journal-title":"Obstet. Gynecol."},{"issue":"Supp.","key":"10.1254\/jjp.63.269_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2265.1977.tb03343.x","article-title":"Use of bromocriptine in the galactorrhea-amenorrhea syndromes: the Canadian cooperative study","volume":"6","author":"Friessen","year":"1977","journal-title":"J. Clin. Endocrinol."},{"key":"10.1254\/jjp.63.269_bib5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9378(83)90010-8","article-title":"Management of patients with hyperprolactinemia and normal or abnormal tomograms","volume":"147","author":"Kletzky","year":"1983","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1254\/jjp.63.269_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(84)90518-1","article-title":"Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism","volume":"97","author":"Kehr","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00008877-199000160-00006","article-title":"Unusual interactions between the neuroleptic haloperidol and the dopamine D2 partial agonist, terguride","volume":"1","author":"Stephens","year":"1990","journal-title":"Behav. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0024-3205(83)90089-9","article-title":"Dual action on central dopamine function of transdihydrolisuride, a 9,10-dihydrogenated analogue of the ergot dopamine agonist lisuride","volume":"32","author":"Wachtel","year":"1983","journal-title":"Life Sci."},{"key":"10.1254\/jjp.63.269_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00008877-199106000-00007","article-title":"Terguride, a dopamine D2 partial agonist, as a discriminative stimulus in rats","volume":"2","author":"Yamaguchi","year":"1991","journal-title":"Behav. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib10","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/0024-3205(84)90537-X","article-title":"Novel 8\u03b1-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats","volume":"35","author":"Wachtel","year":"1984","journal-title":"Life Sci."},{"key":"10.1254\/jjp.63.269_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0015-0282(16)59823-9","article-title":"Terguride-a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine","volume":"49","author":"Ciccarelli","year":"1988","journal-title":"Fertil. Steril."},{"key":"10.1254\/jjp.63.269_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1530\/acta.0.1110460","article-title":"Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride","volume":"1ll","author":"Graef","year":"1986","journal-title":"Acta Endocrinol."},{"key":"10.1254\/jjp.63.269_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(88)90696-6","article-title":"Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary","volume":"151","author":"Dall\u2019Ara","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib14","series-title":"Excerpta Medica International Congress Series No. 288","first-page":"270","article-title":"Histological and histochemical differentiation of the glandular cells of the anterior pituitary in various experimental animals","author":"EI Etreby","year":"1972"},{"key":"10.1254\/jjp.63.269_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1071\/BI9810435","article-title":"Progesterone control of the initiation of lactose synthesis in the rat","volume":"34","author":"Nicholas","year":"1981","journal-title":"Aust. J. Biol. Sci."},{"key":"10.1254\/jjp.63.269_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0014-2999(73)90138-6","article-title":"On the mode of action of apomorphine","volume":"21","author":"Costali","year":"1972","journal-title":"Eur. J. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib17","first-page":"105","article-title":"Dual activation by lisuride of central serotonin 5-\u0397\u03a41A and dopamine D2 receptor sites: drug discrimination and receptor binding studies","volume":"2","author":"Kimura","year":"1991","journal-title":"Behav. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol regent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1254\/jjp.63.269_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(87)90604-2","article-title":"Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion","volume":"135","author":"Rovescalli","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/joe.0.0750093","article-title":"A homologous radioimmunoassay for canine prolactin and its application in various physiological states","volume":"75","author":"Graef","year":"1977","journal-title":"J. Endocrinol."},{"key":"10.1254\/jjp.63.269_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3181\/00379727-151-39161","article-title":"A rapid radioimmunoassay method of growth hormone in dog plasma","volume":"151","author":"Cocola","year":"1976","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1254\/jjp.63.269_bib22","first-page":"93","article-title":"Development of a radioimmunoassay for canine luteinizing hormone","volume":"75","author":"Boyns","year":"1977","journal-title":"J. Endocrinol."},{"key":"10.1254\/jjp.63.269_bib23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/endo-94-4-1077","article-title":"Studies on the mechanism of the dopamine mediated inhibition of prolactin secretion","volume":"94","author":"MacLeod","year":"1974","journal-title":"Endocrinology"},{"key":"10.1254\/jjp.63.269_bib24","series-title":"Clinical Neuroendocrinology: A Pathophysiological Approach","first-page":"429","article-title":"Pharmacological aspects of the prolactin inhibitor bromocriptine","author":"Del Pozo","year":"1979"},{"key":"10.1254\/jjp.63.269_bib25","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0021-9258(17)38065-1","article-title":"Dopaminergic receptors in the anterior pituitary gland","volume":"253","author":"Caron","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1254\/jjp.63.269_bib26","first-page":"576","article-title":"Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary","volume":"23","author":"Enjalbere","year":"1983","journal-title":"Mol. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0006-291X(84)90414-5","article-title":"Dopamine receptors in rat pituitary and estradiol-induced pituitary tumor; effect of chronic treatment with bromocriptine","volume":"123","author":"Di Paolo","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1254\/jjp.63.269_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1677\/joe.0.1130383","article-title":"Influence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumor growth in vivo in rats","volume":"113","author":"Vrontakis","year":"1987","journal-title":"J. Endocrinol."},{"key":"10.1254\/jjp.63.269_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(87)90651-0","article-title":"The intrinsic activities of the partial dopamine receptor agonists (\u2014)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats","volume":"142","author":"Carlsson","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1254\/jjp.63.269_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0024-3205(88)90100-2","article-title":"The intrinsic activity of (\u2014)-3-PPP (Preclamol) on pituitary DA receptors in female rat is enhanced following chronic DA depletion","volume":"42","author":"Carlsson","year":"1988","journal-title":"Life Sci."},{"key":"10.1254\/jjp.63.269_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/342923a0","article-title":"Alternative splicing directs the expression of two D2 dopamine receptor isoforms","volume":"342","author":"Giros","year":"1989","journal-title":"Nature"},{"key":"10.1254\/jjp.63.269_bib32","unstructured":"Washio, K., Nakashima, H., Yanase, R. and Azuma, H.: Pharmacokinetic studies of terguride (1). Absorption, distribution and excretion in rats. Xenobiotic Metabolism and Disposition (in press) (Abs. in English)"},{"key":"10.1254\/jjp.63.269_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdd.2510060305","article-title":"Pharmacokinetics and phramacodynamics of bromocriptine in the rat","volume":"6","author":"Schran","year":"1985","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1254\/jjp.63.269_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/dev.420150207","article-title":"The lactation-blocking drug bromocriptine and its application to studies of weaning and behavioral development","volume":"15","author":"Martin","year":"1982","journal-title":"Dev. Psychobiol."}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002151981935927X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002151981935927X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:24:25Z","timestamp":1630592665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002151981935927X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993]]}},"alternative-id":["S002151981935927X"],"URL":"https:\/\/doi.org\/10.1254\/jjp.63.269","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1993]]}}}